Last updated on March 2020

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis


Brief description of study

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.

Clinical Study Identifier: NCT03915964

Find a site near you

Start Over

GCM Medical Group PSC

San Juan, Puerto Rico
2.27miles
  Connect »

Mindful Medical Research

San Juan, Puerto Rico
2.64miles
  Connect »

Latin Clinical Trial Center

San Juan, Puerto Rico
4.12miles
  Connect »

Centro Reumatologico de Caguas

Caguas, Puerto Rico
6.58miles
  Connect »